Price
115.6
-1.29%52W Range
Market Cap
₹240.41 Cr
Traded: ₹0.10 Cr (0.04%) 0.0x
Free Float: ₹126.26 Cr (0.08% of FF traded)
Volume · 60D trend
8.56 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +3.0% | +4.0% | +2.0% | -- | -- | Stable |
| Return | +22.0% | +22.0% | +16.0% | +76.0% | -- | Stable |
| Sales | +6.0% | +11.0% | +5.0% | -- | +8.0% | Stable |
| Profit | -1.0% | -44.0% | -73.0% | -- | -89.0% | Decelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17 | 14 | 14 | 13 | 14 | 12 | 12 | 13 | 13 | 11 | 12 | 13 | 13 | 11 |
| Expenses | 14 | 13 | 13 | 12 | 12 | 12 | 11 | 12 | 11 | 10 | 10 | 11 | 10 | 10 |
| Operating Profit | 3 | 0 | 1 | 1 | 1 | -0 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 |
| OPM % | 17.3% | 3.5% | 4.9% | 5.9% | 10.9% | -1.5% | 6.5% | 8.9% | 12.9% | 7.0% | 13.1% | 14.2% | 19.0% | 12.4% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | -0 | -0 | 0 | 1 | 1 | -0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 |
| Tax % | 39.6% | -33.3% | -29.7% | -71.4% | 24.7% | 70.2% | -44.2% | 9.1% | 28.2% | -200.0% | 26.7% | 28.6% | 28.0% | 31.6% |
| Net Profit | 1 | -0 | -0 | 0 | 1 | 0 | -0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Exceptional Items | -- | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| EPS (Rs) | 0.3 | -0.1 | -0.1 | 0.1 | 0.3 | 0.1 | -0.1 | 0.1 | 0.3 | 0.0 | 0.3 | 0.4 | 0.7 | 0.3 |
| Sales Growth (YoY) | -- | 18.3% | 10.6% | 1.0% | 4.9% | 5.8% | 1.8% | 1.4% | 2.5% | -2.6% | -0.9% | 7.3% | 5.9% | 5.7% |
| Sales Growth (QoQ) | -- | 0.4% | 3.9% | -3.5% | 17.5% | -6.0% | -5.1% | 0.2% | 18.5% | -9.6% | -5.5% | 1.3% | 12.5% | -- |
| OP Growth (YoY) | 99.3% | 382.4% | -16.5% | -33.0% | -10.8% | -122.4% | -50.0% | -36.5% | -30.5% | -45.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | 514.6% | -27.3% | -14.3% | -48.0% | 970.6% | -121.5% | -31.3% | -30.7% | 118.4% | -51.9% | -12.7% | -24.3% | 71.9% | -- |
| Profit Growth (YoY) | 13.0% | -224.0% | -8.3% | 20.0% | -12.9% | 733.3% | -135.8% | -88.1% | -55.1% | -95.4% | -42.2% | -6.7% | 0.7% | 18.0% |
| EPS Growth (YoY) | -- | -225.0% | -8.3% | 20.0% | -13.3% | 1100.0% | -137.5% | -87.8% | -54.5% | -96.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -15.4% | -316.7% | -76.9% | 116.7% | 200.0% | -340.0% | -83.3% | 2900.0% | -96.9% | -21.9% | -37.9% | 112.9% | -- |
| OP Margin | -- | 3.5% | 4.9% | 5.9% | 10.9% | -1.5% | 6.5% | 8.9% | 12.9% | 7.0% | 13.1% | 14.2% | 19.0% | 12.4% |
| Net Margin | -- | -2.4% | -1.9% | 0.9% | 4.0% | 2.2% | -2.0% | 0.8% | 4.8% | 0.2% | 5.5% | 6.7% | 11.0% | 5.8% |
| Material Cost % | -- | 30.4% | 30.8% | 31.8% | 31.0% | 32.8% | 30.8% | 31.4% | 29.9% | 31.4% | 31.8% | 32.8% | 31.1% | 32.9% |
| Employee Cost % | -- | 23.9% | 23.2% | 22.5% | 21.0% | 24.9% | 24.2% | 23.1% | 21.8% | 23.6% | 21.0% | 19.3% | 17.9% | 20.2% |
| P/S | 4.20 | 4.48 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 1651.43 | 2890.25 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.00 | 4.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Newspaper Advertisements published for Standalone Unaudited Financial Results for the quarter ended June 30, 2026
Standalone Unaudited Financial Results for the quarter ended June 30, 2026.
Approved Standalone Unaudited Financial Results for the quarter ended June 30, 2026.
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
Newspaper Advertisements published for Standalone Audited Financial Results approved by the Board of Directors at its meeting held on May 26, 2026
Standalone Audited Financial Results for the quarter and year ended March 31, 2026.
Reappointment of Internal Auditor of the Company
Standalone Audited Financial Results For Quarter And Year Ended March 31, 2026 and reappointment of P Vishnu Adithan as Internal Auditor of the Company
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Standalone ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sangeetha Sundaramoorthy
Please refer the attachment
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Please refer attachment
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/03/2026 ,inter alia, to consider and approve the proposal ....
Imposition of Fine
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sangeetha Sundaramoorthy
Board comments on imposition of fine under Regulation 17(1A) of SEBI (LODR), 2015
Newspaper Publication for the Financial results approved by the Board of Directors in its meeting held on February 11, 2026.
Appointment of Company Secretary & Compliance Officer
Approved Unaudited Standalone Financial Results for the quarter and year ended December 31, 2025 and appointment of Company Secretary & Compliance Officer
Approved Unaudited Standalone Financial Results for the quarter and year ended December 31, 2025 and appointment of Company Secretary & Compliance Officer
Resignation of company secretary & compliance officer
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vramath Financial Services Pvt Ltd & PACs
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Consideration ....
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Results of voting by postal ballot and scrutinizers report
for the quarter ended 31.12.2025
for the quarter and year ended 31st December 2025
Revision in voting period mentioned in the earlier announcement
Postal Ballot Notice and Remote e-voting process
For circulation to shareholders
Appointment of S Natesan for a second term of 5 years
imposition of fine
Imposition of fine
of the financial results approved by the Board of Directors in its meeting held on 12th November 2025
approval of unaudited financial results for the quarter and year ended 30th September 2025
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited ....
As on 30.09.2025
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
The 10th center of Lotus Eye Hospital and Institute Limited
for the quarter ended 30th September 2025
AGM proceedings with conclusion time
Proceedings of 28th Annual general meeting
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sangeetha Sundaramoorthy
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
E-voting instruction to be followed to caste vote in the Annual General Meeting scheduled to be convened on 23rd September 2025
We hereby attach the Annual report for the financial year 2024-25
Annual Reports
14